National Institutes of Health recently published a catastrophically flawed case report on kratom, with multiple references which directly contradict the paper’s conclusions, and one source that simply doesn’t exist.

On August 30th, the DEA filed a notice of intent to temporarily designate Kratom as a schedule 1 drug. That notice listed 33 footnotes, but the actual references themselves were not included in the document itself. The same day, a FOIA was filed for that information … to which the agency responded with with press releases and copies of federal laws.